87 related articles for article (PubMed ID: 9202252)
1. Regulation of apoptosis in uterine leiomyomata.
Burroughs KD; Kiguchi K; Howe SR; Fuchs-Young R; Trono D; Barrett JC; Walker C
Endocrinology; 1997 Jul; 138(7):3056-64. PubMed ID: 9202252
[TBL] [Abstract][Full Text] [Related]
2. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo.
Howe SR; Gottardis MM; Everitt JI; Walker C
Endocrinology; 1995 Nov; 136(11):4996-5003. PubMed ID: 7588234
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.
Walker CL; Burroughs KD; Davis B; Sowell K; Everitt JI; Fuchs-Young R
J Soc Gynecol Investig; 2000; 7(4):249-56. PubMed ID: 10964025
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators.
Fuchs-Young R; Howe S; Hale L; Miles R; Walker C
Mol Carcinog; 1996 Nov; 17(3):151-9. PubMed ID: 8944075
[TBL] [Abstract][Full Text] [Related]
5. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen.
Howe SR; Pass HI; Ethier SP; Matthews WJ; Walker C
Cancer Res; 1996 Sep; 56(17):4049-55. PubMed ID: 8752178
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
7. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism.
Sumitani H; Shozu M; Segawa T; Murakami K; Yang HJ; Shimada K; Inoue M
Endocrinology; 2000 Oct; 141(10):3852-61. PubMed ID: 11014242
[TBL] [Abstract][Full Text] [Related]
8. Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma.
Walker CL
Recent Prog Horm Res; 2002; 57():277-94. PubMed ID: 12017548
[TBL] [Abstract][Full Text] [Related]
9. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
10. Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat.
Burroughs KD; Fuchs-Young R; Davis B; Walker CL
Biol Reprod; 2000 Nov; 63(5):1322-30. PubMed ID: 11058535
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.
Gamage SD; Bischoff ED; Burroughs KD; Lamph WW; Gottardis MM; Walker CL; Fuchs-Young R
J Pharmacol Exp Ther; 2000 Nov; 295(2):677-81. PubMed ID: 11046105
[TBL] [Abstract][Full Text] [Related]
12. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines.
Howe SR; Gottardis MM; Everitt JI; Goldsworthy TL; Wolf DC; Walker C
Am J Pathol; 1995 Jun; 146(6):1568-79. PubMed ID: 7539981
[TBL] [Abstract][Full Text] [Related]
13. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 inhibits apoptosis through a sphingosine kinase 1-dependent mechanism in uterine leiomyoma ELT3 cells.
Raymond MN; Bole-Feysot C; Banno Y; Tanfin Z; Robin P
Endocrinology; 2006 Dec; 147(12):5873-82. PubMed ID: 16959847
[TBL] [Abstract][Full Text] [Related]
15. Sex steroidal regulation of uterine leiomyoma growth and apoptosis.
Maruo T; Ohara N; Wang J; Matsuo H
Hum Reprod Update; 2004; 10(3):207-20. PubMed ID: 15140868
[TBL] [Abstract][Full Text] [Related]
16. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids.
Salama SA; Nasr AB; Dubey RK; Al-Hendy A
J Soc Gynecol Investig; 2006 Dec; 13(8):542-50. PubMed ID: 17088081
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyomas: mechanisms of tumorigenesis.
Houston KD; Hunter DS; Hodges LC; Walker CL
Toxicol Pathol; 2001; 29(1):100-4. PubMed ID: 11215673
[TBL] [Abstract][Full Text] [Related]
18. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
[TBL] [Abstract][Full Text] [Related]
19. The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.
Shushan A; Rojansky N; Laufer N; Klein BY; Shlomai Z; Levitzki R; Hartzstark Z; Ben-Bassat H
Hum Reprod; 2004 Sep; 19(9):1957-67. PubMed ID: 15205403
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate.
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Inoue M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5405-11. PubMed ID: 11701714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
